膀胱癌上皮间质转化的研究进展

杨玉帛; 冯德超; 王晓明; 白云金; 唐寅; 魏强; 韩平

doi:10.13201/j.issn.1001-1420.2018.11.016

膀胱癌上皮间质转化的研究进展

- 四川大学华西医院泌尿外科/泌尿外科研究所(成都, 610041)
基金项目:
四川省卫计委科研课题重点研发项目 (编号16ZD012)

四川省科技厅重点研发项目 (编号18ZDYF195)

详细信息

通讯作者: 韩平,E-mail:hanpingwch@163.com

中图分类号: R737.14

收稿日期: 2018-08-02

Research progress of epithelial-mesenchymal transition in bladder cancer

- Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China

More Information

Corresponding author: HAN Ping, E-mail: hanpingwch@163.com

Received Date: 02 August 2018

摘要

摘要: 膀胱癌是常见的泌尿系恶性肿瘤,具有高复发、高进展、高异质性等特点。如何解决上述问题,需要从分子生物学层面来更好的认识膀胱癌,其中上皮间质转化(EMT)领域是近年来研究的热点,故本文将对近年来膀胱癌的EMT相关研究进展作一综述。
- 膀胱癌 /
- 上皮间质转化
Abstract: Bladder cancer is a common malignant tumor of the urinary system.It is characterized by high recurrence, high progression and high heterogeneity.How to solve these problems requires a better understanding of bladder cancer due to molecular biology.A lot of studies have focused on epithelial-mesenchymal transition in recent years.Therefore, this article reviewed the research progress of epithelial-mesenchymal transition of bladder cancer.
- bladder cancer /
- epithelial-mesenchymal transition

HTML全文

参考文献(64)

[1]	Siegel R L, Miller K D, Jemal A.Cancer statistics, 2018[J].CA Cancer J Clin, 2018, 68 (1):7-30.
[2]	Chen W, Zheng R, Zhang S, et al.Cancer incidence and mortality in China, 2013[J].Cancer Lett, 2017, 401:63-71.
[3]	Chen W, Zheng R, Baade P D, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2):115-132.
[4]	Brabletz T, Kalluri R, Nieto M A, et al.EMT in cancer[J].Nat Rev Cancer, 2018, 18 (2):128-134.
[5]	Zeisberg M, Neilson E G.Biomarkers for epithelial-mesenchymal transitions[J].J Clin Invest, 2009, 119 (6):1429-1437.
[6]	Yang J, Du X, Wang G, et al.Mesenchymal to epithelial transition in sarcomas[J].Eur J Cancer, 2014, 50 (3):593-601.
[7]	Sehgal P, Kong X, Wu J, et al.Epidermal growth factor receptor and integrins control force-dependent vinculin recruitment to E-cadherin junctions[J].J Cell Sci, 2018, 131 (6):pii:jcs206656.
[8]	董大海, 赵军, 孙立江, 等.E钙黏着素与波形蛋白在膀胱癌中的表达及意义[J].现代泌尿外科杂志, 2010, 15 (1):22-24.
[9]	Hussein S, Mosaad H, Rashed H E, et al.Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features[J].Mol Biol Rep, 2017, 44 (4):365-377.
[10]	Christou N, Perraud A, Blondy S, et al.The extracellular domain of E cadherin linked to invasiveness in colorectal cancer:a new resistance and relapses monitoring serumbio marker?[J].J Cancer Res Clin Oncol, 2017, 143 (7):1177-1190.
[11]	Patriarca C, Macchi R M, Marschner A K, et al.Epithelial cell adhesion molecule expression (CD326) in cancer:a short review[J].Cancer Treat Rev, 2012, 38 (1):68-75.
[12]	van der Fels C A M, Rosati S, de Jong I J.EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder:A Pilot Study[J].Int J Mol Sci, 2017, 18 (8):pii:E1802.
[13]	Abrahamsson J, Aaltonen K, Engilbertsson H, et al.Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder:Association with tumor stage, lymph node metastases, FDG-PET findings, and survival[J].Urol Oncol, 2017, 35 (10):606.
[14]	Shiota M, Yokomizo A, Itsumi M, et al.Twist1and Y-box-binding protein-1 promote malignant potential in bladder cancer cells[J].BJU Int, 2011, 108 (2 Pt 2):E142-E149.
[15]	Zhao J, Dong D, Sun L, et al.Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer[J].Int Braz JUrol, 2014, 40 (2):179-189.
[16]	Suárez-Bonnet A, Herráez P, Aguirre M, et al.Expression of cell cycle regulators, 14-3-3σand p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder[J].Urol Oncol, 2015, 33 (7):332.
[17]	巢海潮, 邓雷弘, 董志峰.膀胱癌组织miR-451表达及其与E-cadherin和Vimentin表达相关性[J].中华肿瘤防治杂志, 2017, 24 (15):1065-1070.
[18]	Zhao Z, Rahman M A, Chen Z G, et al.Multiple biological functions of Twist1 in various cancers[J].Oncotarget, 2017, 8 (12):20380-20393.
[19]	Song Y H, Shiota M, Yokomizo A, et al.Twist1 and Y-box-binding protein-1are potential prognostic factors in bladder cancer[J].Urol Oncol, 2014, 32 (1):31.
[20]	Wei Z, Shan Z, Shaikh Z A.Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail[J].Toxicol Appl Pharmacol, 2018, 344:46-55.
[21]	Santi R, Cai T, Nobili S, et al.Snail immunohistochemical overexpression correlates to recurrence risk in nonmuscle invasive bladder cancer:results from a longitudinal cohort study[J].Virchows Arch, 2018, 472 (4):605-613.
[22]	Salehi S, Mansoori B, Mohammadi A, et al.An analysis of suppressing migratory effect on human urinary bladder cancer cell line by silencing of snail-1[J].Biomed Pharmacother, 2017, 96:545-550.
[23]	Singh R, Mandhani A, Agrawal V, et al.Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients[J].Cancer Microenviron, 2018, 11 (1):23-39.
[24]	符小宝, 段建敏, 李庆超, 等.EDIL3在膀胱癌中的表达及与VEGF相关性的研究[J].临床泌尿外科杂志, 2017, 32 (3):184-188.
[25]	Wu K, Zeng J, Zhou J, et al.Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development[J].Urol Oncol, 2013, 31 (8):1751-1760.
[26]	Xu M, Li J, Wang X, et al.MiR-22suppresses epithelialmesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop[J].Cell Death Dis, 2018, 9 (2):209.
[27]	Zhang S, Zhang C, Liu W, et al.MicroRNA-24upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3[J].Int J Oncol, 2015, 47 (4):1351-1360.
[28]	Zhang S, Pan D, Jia X M, et al.The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damageinduced NF-κB activation and cell survival[J].Protein Cell, 2017, 8 (11):856-860.
[29]	Liu L, Qiu M, Tan G, et al.miR-200cinhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3[J].JTransl Med, 2014, 12:305-305.
[30]	Adam L, Zhong M, Choi W, et al.miR-200expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy[J].Clin Cancer Res, 2009, 15 (16):5060-5072.
[31]	Chen M F, Zeng F, Qi L, et al.Transforming growth factor-β1 induces epithelial-mesenchymal transition and increased expression of matrix metalloproteinase-16via miR-200bdownregulation in bladder cancer cells[J].Mol Med Rep, 2014, 10 (3):1549-1554.
[32]	Shen J, Zhang J, Xiao M, et al.MiR-203 Suppresses Bladder Cancer Cell Growth and Targets the Twist1[J].Oncol Res, 2017.
[33]	Li Q, Zhou L, Wang M, et al.MicroRNA-613impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14[J].Biomed Pharmacother, 2018, 98:636-642.
[34]	Wang J, Ge W, Wang Y, et al.MiR-613suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1[J].J Cell Biochem, 2018, 119 (7):5118-5125.
[35]	Yu H, Duan P, Zhu H, et al.miR-613inhibits bladder cancer proliferation and migration through targeting SphK1[J].Am J Transl Res, 2017, 9 (3):1213-1221.
[36]	Du X, Fan W, Chen Y.microRNA-520finhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1[J].Gene, 2018, 657:30-38.
[37]	Hong S, Bi M, Chen S, et al.MicroRNA-520fsuppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2)[J].Neoplasma, 2016, 63 (6):873-879.
[38]	van Kampen J G M, van Hooij O, Jansen C F, et al.miR-NA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2[J].Cancer Res, 2017, 77 (8):2008-2017.
[39]	Mo M, Zhou M, Wang L, et al.CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells[J].PLoS One, 2015, 10 (3):e0119506.
[40]	Zhou M, Wang S, Hu L, et al.miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7[J].BMC Urol, 2016, 16 (1):64.
[41]	Wang Y, Wei J, Zhang S, et al.Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma[J].Tumour Biol, 2015, 36 (11):8781-8787.
[42]	Huang X, Zhu H, Gao Z, et al.Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p[J].J Biol Chem, 2018, 293 (18):6693-6706.
[43]	Xu Y, Han Y F, Zhu S J, et al.miRNA-148ainhibits cell growth of papillary thyroid cancer through STAT3 and PI3K/AKT signaling pathways[J].Oncol Rep, 2017, 38 (5):3085-3093.
[44]	Wang X, Liang Z, Xu X, et al.miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer[J].Cell Death Dis, 2016, 7 (12):e2503.
[45]	Tan J, Qiu K, Li M, et al.Double-negative feedback loop between long non-coding RNA TUG1 and miR-145promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells[J].FEBS Letters, 2015, 589 (20 Pt B):3175-3181.
[46]	Xu X, Zhu Y, Liang Z, et al.c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelialmesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling[J].Cell Death Dis, 2016, 7:e2088.
[47]	Mao X W, Xiao J Q, Li Z Y, et al.Effects of microRNA-135aon the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway[J].Exp Mol Med, 2018, 50 (1):e429.
[48]	Danesh H, Hashemi M, Bizhani F, et al.Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293polymorphisms and the risk of breast cancer in a sample of Iranian population[J].Gene, 2018, 647:73-78.
[49]	Wu D, Chen B, Cui F, et al.Hypoxia-induced microR-NA-301bregulates apoptosis by targeting Bim in lung cancer[J].Cell Prolif, 2016, 49 (4):476-483.
[50]	Yan L, Wang Y, Liang J, et al.MiR-301bpromotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1[J].Biochem Cell Biol, 2017, 95 (5):571-577.
[51]	郑林峰, 倪型灏, 程国平, 等.膀胱尿路上皮癌中DAB2IP和β-catenin的表达及临床意义[J].临床与实验病理学杂志, 2017, 33 (4):398-402.
[52]	李佩琴, 杨少芬, 于莉娜.DAB2IP在前列腺癌中的表达及其临床意义[J].实用医学杂志, 2016, 32 (2):242-244.
[53]	Huang J, Wang B, Hui K, et al.miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion[J].Oncol Rep, 2016, 36 (3):1693-1701.
[54]	Zhu Z, Xu L, Wan Y, et al.Inhibition of E-cadherin expression by lnc-RNA H19to facilitate bladder cancer metastasis[J].Cancer Biomark, 2018, 22 (2):275-281.
[55]	Seitz A K, Christensen L L, Christensen E, et al.Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer[J].Sci Rep, 2017, 7 (1):395.
[56]	Tuo Z, Zhang J, Xue W.LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway[J].Biochem Biophys Res Commun, 2018, 499 (4):875-881.
[57]	Xing Y H, Chen L L.Processing and roles of snoRNA-ended long noncoding RNAs[J].Crit Rev Biochem Mol Biol, 2018 Sep 25:1-11.
[58]	Wang C, Tao W, Ni S, et al.Upregulation of lncRNA snoRNA host gene 6regulates NUAK family SnF1-like kinase-1expression by competitively binding microR-NA-125band interacting with Snail1/2in bladder cancer[J].J Cell Biochem, 2018.
[59]	Feng F, Chen A, Huang J, et al.Long noncoding RNASNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT 3/Wnt/β-catenin pathway axis[J].J Cell Biochem, 2018, 119 (11):9408-9418.
[60]	戴利和, 马重, 曾蜀雄, 等.膀胱癌循环肿瘤细胞的检测及临床应用研究进展[J].临床泌尿外科杂志, 2016, 31 (2):176-179.
[61]	Raimondi C, Carpino G, Nicolazzo C, et al.PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients:A molecular shield to evade immune system?[J].Oncoimmunology, 2017, 6 (12):e1315488.
[62]	Sabine K B, Oliver H, Diethelm W, et al.Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells[J].Breast Cancer Res, 2012, 14 (1):R15.
[63]	Chalfin H J, Kates M, van der Toom E E, et al.Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method[J].Urology, 2018, 115:82-86.
[64]	杨玉帛, 白云金, 唐寅, 等.差相富集-免疫荧光原位杂交技术检测膀胱癌患者循环肿瘤细胞的初步研究[J].四川大学学报 (医学版), 2017, 48 (4):605-609.